Search

Your search keyword '"M, Ardizzoia"' showing total 4 results
Start Over Author "M, Ardizzoia" Journal minerva endocrinologica
4 results on '"M, Ardizzoia"'

1. [Postmenopausal osteoporosis]

Author

A, Bocci, M, Massobrio, and M, Ardizzoia

Subjects
Adult, Lipoproteins, Antithrombin III, Body Weight, Angiotensinogen, Estrogens, Middle Aged, Diet, Hyperprolactinemia, Parathyroid Hormone, Body Composition, Humans, Osteoporosis, Female, Menopause, Triglycerides, Aged
Published
1985

2. [Application of new therapeutic approaches in the prevention of osteoporosis in women]

Author

A, Bocci, C, Campagnoli, and M, Ardizzoia

Subjects
Calcitonin, Estradiol, Physical Exertion, Humans, Osteoporosis, Drug Therapy, Combination, Estrogens, Female, Middle Aged, Progestins, Administration, Cutaneous, Diet
Abstract

The prevention of female osteoporosis is based on: a) promoting the achievement of optimal bone mass at the time of menopause; b) minimizing subsequent rarefaction especially in fast bone losers. Both these objectives can be partly attained by appropriate behaviour (balanced diet with adequate calcium intake, physical exercise) but often with additional preventive treatment that is undoubtedly easier to undertake since the introduction of new therapeutic approaches like the use of transdermal estradiol (TDE) and the salmon calcitonin (CT) nasal spray. Certain situations, chronic hypo-estrogenism (amenorrhea caused by primary ovarian deficit and primary or secondary hypothalamic hypogonadotropinemia) should be rectified by replacement estrogen-progestin treatment before the onset of menopause. Protracted treatment of this kind can also be used beneficially in patients identified as at risk of osteoporosis during the climacteric and where it is advisable to minimise the hepatocellular action of the estrogens TDE will be the treatment of choice. In both phases the CT spray can be used preventively wherever there are contraindications to the use of the estrogens and a real risk of osteoporosis.

Published
1989

3. [Postmenopausal osteoporosis].

Author

Bocci A, Massobrio M, and Ardizzoia M

Subjects
Adult, Aged, Angiotensinogen biosynthesis, Antithrombin III biosynthesis, Body Composition, Body Weight, Diet, Estrogens blood, Female, Humans, Hyperprolactinemia complications, Lipoproteins biosynthesis, Middle Aged, Parathyroid Hormone physiology, Triglycerides blood, Menopause, Osteoporosis etiology
Published
1985

4. [Application of new therapeutic approaches in the prevention of osteoporosis in women].

Author

Bocci A, Campagnoli C, and Ardizzoia M

Subjects
Administration, Cutaneous, Calcitonin administration & dosage, Diet, Drug Therapy, Combination, Estradiol administration & dosage, Estrogens administration & dosage, Female, Humans, Middle Aged, Osteoporosis drug therapy, Physical Exertion, Progestins administration & dosage, Osteoporosis prevention & control
Abstract

The prevention of female osteoporosis is based on: a) promoting the achievement of optimal bone mass at the time of menopause; b) minimizing subsequent rarefaction especially in fast bone losers. Both these objectives can be partly attained by appropriate behaviour (balanced diet with adequate calcium intake, physical exercise) but often with additional preventive treatment that is undoubtedly easier to undertake since the introduction of new therapeutic approaches like the use of transdermal estradiol (TDE) and the salmon calcitonin (CT) nasal spray. Certain situations, chronic hypo-estrogenism (amenorrhea caused by primary ovarian deficit and primary or secondary hypothalamic hypogonadotropinemia) should be rectified by replacement estrogen-progestin treatment before the onset of menopause. Protracted treatment of this kind can also be used beneficially in patients identified as at risk of osteoporosis during the climacteric and where it is advisable to minimise the hepatocellular action of the estrogens TDE will be the treatment of choice. In both phases the CT spray can be used preventively wherever there are contraindications to the use of the estrogens and a real risk of osteoporosis.

Published
1989

Catalog

Books, media, physical & digital resources
See catalog results